Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Gold Price Hits New Record, Breaking US$2,950 for First Time

by admin February 21, 2025
February 21, 2025
Gold Price Hits New Record, Breaking US$2,950 for First Time

The gold price reached yet another record high on Thursday (February 20), breaking US$2,950 per ounce.

The yellow metal rose as high as US$2,954.72 before pulling back to the US$2,935 level, pushed upward by ever-increasing global turmoil, including tariff talks and ongoing tensions between Russia and Ukraine.

Gold price chart, February 13 to 20, 2025.

Gold has also made headlines this week on the back of calls for an audit of Fort Knox.

The Kansas-based army installation reportedly holds 4,580 metric tons of gold, but despite ongoing requests has not been fully audited since 1953. Tech billionaire Elon Musk has suggested that the newly established US Department of Government Efficiency, better known as DOGE, should take on the task.

Long-term factors supporting gold include strong central bank demand and buying from eastern investors.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Exceptional silver and cobalt assays from seaweed
next post
RUA GOLD Closes C$5.75 Million Brokered Offering Including the Full Exercise of Over-Allotment Option

Related Posts

Harmony Gold to Acquire MAC Copper in US$1.03...

June 2, 2025

Top 5 Canadian Mining Stocks This Week: Lion...

May 3, 2025

Harvest Gold Soil Sampling Program Reveals Several New...

May 23, 2025

RIU Conference Presentation

May 6, 2025

Group Eleven Announces Appointment of Jasmine Lau as...

May 30, 2025

Editor’s Picks: Gold Price Breaks US$4,300, Silver Soars...

October 17, 2025

Letter from the CEO: Unlocking the True Value...

March 27, 2025

California Touts US$540 Billion Salton Sea Lithium Discovery

April 2, 2025

Top 5 Small-cap Pharma Stocks in 2025

April 9, 2025

Significant Enlargement of Exploration Program

September 15, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 3

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved